0

    524604

    ADLINE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ADLINE CHEM LAB LIMITED Share Price Today

    Investment Returns

    Over 1 Month 0.00% Over 3 Months 27.14% Over 6 Months 35.02% Over 1 Year -8.40%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ADLINE CHEM LAB LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 8.40
    • P/E Ratio (TTM) -29.96
    • Beta -0.71
    • Book Value / share -3.02
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.09
    info icon alternate text

    ADLINE CHEM LAB LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.11
    Net Profit -0.09
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.17
    EBITDA -0.07
    Effective Tax Rate (%) 9.09
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.07
    Net Profit -0.06
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.01
    EBITDA -0.03
    Effective Tax Rate (%) 14.28
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.08
    Net Profit -0.07
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.01
    EBITDA -0.05
    Effective Tax Rate (%) 12.50
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.06
    Net Profit -0.05
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.01
    EBITDA -0.03
    Effective Tax Rate (%) 16.66
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.09
    Net Profit 0.21
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.04
    EBITDA 0.19
    Effective Tax Rate (%) -31.25
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.32
    Net Profit -0.28
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.48
    EBITDA -0.14
    Effective Tax Rate (%) 12.50
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.45
    Net Profit -0.13
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.02
    EBITDA -0.07
    Effective Tax Rate (%) 33.33
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.30
    Net Profit -0.27
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.05
    EBITDA -0.18
    Effective Tax Rate (%) 10.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.88
    Net Profit -4.23
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -7.24
    EBITDA -4.14
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.74
    Operating Expense 1.39
    Net Profit 0.72
    Net Profit Margin (%) 97.29
    Earnings Per Share (EPS) 1.23
    EBITDA 1.08
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -2.55
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share -2.35
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -2.68
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.45
    EBITDA Margin 0.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4.53
    ROE % -10.55
    ROCE % -7.40
    Total Debt to Total Equity 0.83
    EBITDA Margin -14.86
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3.30
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.04
    EBITDA Margin -3.63
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.06
    Total Assets 0.07
    Total Liabilities 0.07
    Total Equity -1.49
    Share Outstanding 0
    Price to Book Ratio -5.20
    Return on Assets (%) -175.09
    Return on Capital (%) 2360.71
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 0.04
    Total Liabilities 0.04
    Total Equity -1.37
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -644.07
    Return on Capital (%) 1998.53
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.06
    Total Assets 0.06
    Total Liabilities 0.06
    Total Equity -1.56
    Share Outstanding 0
    Price to Book Ratio -2.01
    Return on Assets (%) -6858.26
    Return on Capital (%) 1806.58
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 4.87
    Total Liabilities 4.87
    Total Equity 2.64
    Share Outstanding 0
    Price to Book Ratio 1.45
    Return on Assets (%) 14.72
    Return on Capital (%) 18.1
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments -0.15
    Total Assets 5.63
    Total Liabilities 5.63
    Total Equity 1.93
    Share Outstanding 0
    Price to Book Ratio 1.55
    Return on Assets (%) -22.77
    Return on Capital (%) -28.96
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.20
    Cash from Operations -0.32
    Cash from Investing 0.00
    Cash from Financing 0.24
    Net change in Cash 0.02
    Free Cash Flow -0.32
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.30
    Cash from Operations -0.16
    Cash from Investing 0.00
    Cash from Financing 0.14
    Net change in Cash -0.01
    Free Cash Flow -0.16
    Particulars MAR 2023 (Values in Cr)
    Net Income -4.23
    Cash from Operations 0.01
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.01
    Free Cash Flow 0.01
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.71
    Cash from Operations 0.21
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.20
    Free Cash Flow 0.21
    Particulars MAR 2021 (Values in Cr)
    Net Income -1.28
    Cash from Operations -0.29
    Cash from Investing 0.11
    Cash from Financing -0.03
    Net change in Cash -0.20
    Free Cash Flow -0.28
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.45 13.46 1.57 248.68 23.12 38.85
    BLISS GVS PHARMA LTD 463.55 37.26 4.12 4916.24 118.35 552.90
    CIPLA LTD. 1410.90 31.85 3.31 113978.90 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 432.60 20.23 3.13 1273.18 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2513.25 44.25 18.77 42575.97 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.45 22.69 4.18 248.68 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 510.50 22.88 3.98 1475.89 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8000.10 104.55 22.91 20000.25 7630.00 9850.00
    BLISS GVS PHARMA LTD 463.55 50.11 4.25 4916.24 118.35 552.90

    ADLINE CHEM LAB LIMITED shareholding pattern

    Holding
    74.14%
    25.85%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ADLINE CHEM LAB LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    14.38 4.96 redarrow
    red-green-graph indicator
    0 Bearish
    0 Bullish
    • 5 Days 0.00
    • 26 Days 0.00
    • 10 Days 0.00
    • 50 Days 0.00
    • 12 Days 0.00
    • 100 Days 0.00
    • 20 Days 0.00
    • 200 Days 0.00
    14.38 PIVOT
    First Support 14.38 First Resistance 14.38 Second Support 14.38 Second Resistance 14.38 Third Support 14.38 Third Resistance 14.38
    RSI 62.44 ADX 49.27 MACD 0.00 Williams % R -23.26 Commodity Channel Index (CCI) 91.49
    Date 2026-07-13 Week 100.00 Same Day 100.00 Month 100.00
    1 Year -0.72 3 Year 0.11
    Over 1 Month
    0.00% down
    Over 1 Year
    -8.40% down
    Over 3 Months
    27.14% down
    Over 3 Years
    18.05% down
    Over 6 Months
    35.02% down
    Over 5 Years
    21.86% down

    ADLINE CHEM LAB LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Adline Chem Lab Ltd?

    Answer Field

    Adline Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 14.38 as on Jul 13 2026 12:00 AM.

    What is the Market Cap of Adline Chem Lab Ltd Share?

    Answer Field

    The market cap of Adline Chem Lab Ltd for NSE ₹ 0.00 & for BSE ₹ 8.40 as on Jul 13 2026 12:00 AM.

    What is the 52 Week High and Low of Adline Chem Lab Ltd?

    Answer Field

    The 52 Week High and Low of Adline Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 18.10 and ₹ 7.60.

    What is 1 year return for Adline Chem Lab Ltd?

    Answer Field

    The 1 year returns on the stock has been -8.40%.

    What is the P/E Ratio of Adline Chem Lab Ltd Share?

    Answer Field

    As on Jul 13 2026 12:00 AM the price-to-earnings (PE) ratio for Adline Chem Lab Ltd share is -29.96.

    What is the PB ratio of Adline Chem Lab Ltd Share?

    Answer Field

    As on Jul 13 2026 12:00 AM, the price-to-book (PB) ratio for Adline Chem Lab Ltd share is -3.02.

    How to Buy Adline Chem Lab Ltd Share?

    Answer Field

    You can trade in Adline Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Adline Chem Lab Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Adline Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Adline Chem Lab Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |